摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

avicine-2H-isoquinoline | 94656-28-7

中文名称
——
中文别名
——
英文名称
avicine-2H-isoquinoline
英文别名
3,4,11,12-Tetrahydro-6,7:2',3'-bis-methylendioxy-1,2-benzophenanthridin;5b,12b,13,14-tetrahydro-[1,3]dioxolo[4,5-j][1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridine
avicine-2H-isoquinoline化学式
CAS
94656-28-7
化学式
C19H15NO4
mdl
——
分子量
321.332
InChiKey
FYYSQXYERHQXIX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.35
  • 重原子数:
    24.0
  • 可旋转键数:
    0.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    49.28
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

点击查看最新优质反应信息

文献信息

  • Studies on the chemical constituents of rutaceous plants. LIV. The development of a versatile method for the synthesis of antitumor-active benzo(c)phenanthridine alkaloids. 4. Limitation of Bischler-Napieralski cyclization and detailed examination of the dehydrogenation of the Bischler-Napieralski p
    作者:HISASHI ISHII、KENICHI HARADA、TOSHIAKI ISHIDA、TAKEO DEUSHI、TAKESHI MASUDA、MITSUGI SAKAMOTO、YUH-ICHIRO ICHIKAWA、TSUTOMU TAKAHASHI、MUNEKAZU ISHIKAWA、TSUTOMU ISHIKAWA
    DOI:10.1248/cpb.32.2971
    日期:——
    In order to establish a versatile method for the preparation of antiumor benzo [c] phenanthridine alkaloids, the reaction steps from the 2-aryl-1-formamido-1, 2, 3, 4-tetrahydronaphthalenes (2) to the fully aromatized benzo [c] phenanthridine derivatives (5) via the 4b, 10b, 11, 12-tetrahydrobenzo [c] phenanthridines (4) in the Robinson preparative sequence were examined in detail. Bischler-Napieralski reaction of the formamide (2) having an alkoxy group at the para position to the cyclizing point of the 2-phenyl ring substituent gave a mixture of the trans-and cistetrahydrobenzo [c] phenanthridines (4) with or without formation of the 2-aryl-3, 4-dihydronaphthalene derivative (6). There is a limitation in that the presence of the alkoxy group at the para position is required for success in cyclizing the formamide derivative (2). Otherwise, the 2-aryl-3, 4-dihydronaphthalene derivative (6) is the sole product. For the dehydrogenation of the resulting trans-and cis-tetrahydrobenzo [c] phenanthridines (trans-and cis-4) into the fully aromatized product (5), catalytic dehydrogenation with 30% palladium-charcoal in p-cymene and 2, 3-dichloro-5, 6-dicyano-1, 4-benzoquinone (DDQ) oxidation in the presence of or in the absence of 5% sodium hydroxide aqueous solution were investigated. The catalytic dehydrogenation provided either the desired fully aromatized product (5) or the dihydrobenzo [c] phenanthridine (8). The species of the product depends upon the species of the starting material (4). The DDQ-oxidation gave a variety of results. The mode of product formation seems to be regulated by various factors, including the reaction conditions, the species of substituents of the starting material (4), and the stereochemistry of the starting material (4). The mechanisms of formation of various products are discussed.
    为了建立一种制备抗肿瘤苯并[c]菲啶生物碱的多功能方法,我们详细研究了从 2-芳基-1-甲酰基-1,2,3,4-四氢 (2) 到完全芳香化的苯并[c]菲啶生物 (5),经由 4b,10b,11,12-四氢苯并[c]菲啶 (4) 的反应步骤。对位上有烷氧基的甲酰胺(2)与 2-苯基环取代基的环化点发生 Bischler-Napieralski 反应,生成了反式和双四氢苯并[c]菲啶(4)的混合物,无论是否形成 2-芳基-3,4-二氢生物(6)。环化甲酰胺衍生物(2)有一个局限性,即需要在对位存在烷氧基。否则,2-芳基-3,4-二氢生物(6)是唯一的产物。为了将生成的反式和顺式四氢苯并[c]菲啶(反式和顺式-4)脱氢为完全芳香化的产物(5),研究了在有或没有 5%氢氧化钠溶液的情况下,在对甲苯和 2,3-二-5,6-二基-1,4-苯醌(DDQ)氧化中使用 30%进行催化脱氢。催化脱氢反应提供了所需的完全芳香化产物(5)或二氢苯并 [c] 菲啶(8)。产物的种类取决于起始物质(4)的种类。DDQ 氧化反应产生了多种结果。产物的形成方式似乎受多种因素的制约,包括反应条件、起始物质的取代基种类 (4) 和起始物质的立体化学结构 (4)。本文讨论了各种产物的形成机理。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)